AC
TAK icon

Asio Capital’s Takeda Pharmaceutical TAK Stock Holding History

Asio Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-103,665
Closed -$1.85M – 86
2020
Q3 		$1.85M Buy
103,665
+7,535
+8% +$137K 1.01% 49
2020
Q2 		$1.72M Buy
96,130
+6,870
+8% +$123K 1.09% 47
2020
Q1 		$1.35M Buy
89,260
+6,223
+7% +$113K 1.16% 43
2019
Q4 		$1.64K Buy
+83,037
New +$1.59M 0.85% 40

Other funds holding TAK

GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM